Article Information
History
- August 7, 2020.
Article Versions
- You are currently viewing Version 1 of this article (August 7, 2020 - 10:11).
- Version 2 (September 2, 2020 - 12:24).
- View Version 3, the most recent version of this article.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- Jennifer N. Rauch1,2,
- Eric Valois1,
- Jose Carlos Ponce-Rojas1,
- Zach Aralis1,
- Ryan S. Lach1,
- Francesca Zappa1,
- Morgane Audouard1,2,
- Sabrina C. Solley1,
- Chinmay Vaidya1,
- Michael Costello1,
- Holly Smith3,
- Ali Javanbakht3,
- Betsy Malear3,
- Laura Polito3,
- Stewart Comer4,5,
- Katherine Arn6,
- Kenneth S. Kosik1,2,
- Diego Acosta-Alvear1,2,
- Maxwell Z. Wilson1,2,7,
- Lynn Fitzgibbons6 and
- Carolina Arias1,2,8,*
- 1University of California Santa Barbara, Department of Molecular, Cellular, and Developmental Biology, Santa Barbara
- 2Neuroscience Research Institute, University of California, Santa Barbara
- 3Student Health Service University of California Santa Barbara, Santa Barbara
- 4Department of Pathology, Santa Barbara Cottage Hospital, Santa Barbara
- 5Pacific Diagnostic Laboratories, Santa Barbara
- 6Department of Medical Education and Division of Infectious Diseases, Santa Barbara Cottage Hospital, Santa Barbara
- 7Center for BioEngineering, University of California, Santa Barbara
- 8Center for Stem Cell Biology and Engineering, University of California, Santa Barbara.
- ↵*Corresponding author; email: carolinaarias{at}ucsb.edu
Posted August 07, 2020.
CRISPR-based and RT-qPCR surveillance of SARS-CoV-2 in asymptomatic individuals uncovers a shift in viral prevalence among a university population
